DK1965831T3 - Anvendelse af C1-inhibitor til forebyggelse af iskæmi-reperfusionsskade - Google Patents

Anvendelse af C1-inhibitor til forebyggelse af iskæmi-reperfusionsskade

Info

Publication number
DK1965831T3
DK1965831T3 DK06824316.1T DK06824316T DK1965831T3 DK 1965831 T3 DK1965831 T3 DK 1965831T3 DK 06824316 T DK06824316 T DK 06824316T DK 1965831 T3 DK1965831 T3 DK 1965831T3
Authority
DK
Denmark
Prior art keywords
inhibitor
reperfusion injury
prevent ischemia
ischemia
prevent
Prior art date
Application number
DK06824316.1T
Other languages
English (en)
Inventor
Maurice Mannesse
Johannes Henricus Nuijens
Frank Pieper
Simoni Maria Grazia De
Gijsbertus Johannes Ziere
Original Assignee
Pharming Intellectual Pty Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Pty Bv filed Critical Pharming Intellectual Pty Bv
Priority claimed from PCT/NL2006/050321 external-priority patent/WO2007073186A2/en
Application granted granted Critical
Publication of DK1965831T3 publication Critical patent/DK1965831T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06824316.1T 2005-12-21 2006-12-19 Anvendelse af C1-inhibitor til forebyggelse af iskæmi-reperfusionsskade DK1965831T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05112630 2005-12-21
US76094406P 2006-01-23 2006-01-23
PCT/NL2006/050321 WO2007073186A2 (en) 2005-12-21 2006-12-19 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury

Publications (1)

Publication Number Publication Date
DK1965831T3 true DK1965831T3 (da) 2011-10-24

Family

ID=36168534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06824316.1T DK1965831T3 (da) 2005-12-21 2006-12-19 Anvendelse af C1-inhibitor til forebyggelse af iskæmi-reperfusionsskade

Country Status (7)

Country Link
CN (2) CN105641688B (da)
DK (1) DK1965831T3 (da)
ES (2) ES2369522T3 (da)
HU (1) HUE035692T2 (da)
LT (1) LT2380587T (da)
PT (2) PT2380587T (da)
SI (1) SI1965831T1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022231B1 (ko) * 2011-12-22 2019-09-19 체에스엘 베링 게엠베하 중추 신경계의 2차 부종을 치료하기 위한 c1-억제제의 용도
WO2014145519A2 (en) * 2013-03-15 2014-09-18 Viropharma Holdings Limited C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficency
EA202092045A1 (ru) * 2018-02-28 2020-11-09 Фарминг Интеллекчуал Проперти Б.В. Лечение и предупреждение преэклампсии

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07285866A (ja) * 1994-02-22 1995-10-31 Eisai Co Ltd 臓器障害予防・治療・改善剤
EP0679396A1 (en) * 1994-03-02 1995-11-02 Pfizer Inc. Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury
CA2502539A1 (en) * 2002-10-17 2004-04-29 Pharming Intellectual Property B.V. Protein modification
CA2515453C (en) * 2003-02-21 2013-09-24 Tanox, Inc. Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
US7544853B2 (en) * 2003-05-16 2009-06-09 Pharming Intellectual Property B.V. C1 inhibitor with short half-life transient treatment

Also Published As

Publication number Publication date
CN105641688B (zh) 2020-06-09
CN105641688A (zh) 2016-06-08
ES2369522T3 (es) 2011-12-01
CN101365478B (zh) 2016-06-22
CN101365478A (zh) 2009-02-11
ES2654816T3 (es) 2018-02-15
PT1965831E (pt) 2011-10-19
SI1965831T1 (sl) 2011-11-30
HUE035692T2 (en) 2018-05-28
LT2380587T (lt) 2018-01-25
PT2380587T (pt) 2018-01-19

Similar Documents

Publication Publication Date Title
NO20085030L (no) Pyrrolopyrimidinforbindelser og deres anvendelser
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
ATE480228T1 (de) Dpp-iv-inhibitor-formulierungen
SMAP200900058A (it) Composti e composizioni come inibitori di proteinachinasi
SM201000108B (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900020A (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900031A (it) Composti e composizioni come inibitori di proteinachinasi
DK2015754T3 (da) Anvendelse af dpp-iv-inhibitorer
CY2014012I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
ATE528296T1 (de) Polymorphe form von 4-ä3-(4- cyclopropancarbonylpiperazin-1-carbonyl)-4- fluorbenzylü-2h-phthalazin-1-on
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1720866T3 (da) Fremgangsmåde
ATE493428T1 (de) Hcv-nukleosidinhibitor
ATE512972T1 (de) Pyrrolopyrazole als wirksame kinaseinhibitoren
DE102005024321B8 (de) Absicherungsschaltung
DK1931315T3 (da) Depotformuleringer af nalbufin
BRPI0717460A2 (pt) Composições de inibidores de chk1
DK2139334T3 (da) Kondenserede heterocykliske 2-cyanophenylforbindelser og sammensætninger og anvendelser deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
NO20055643D0 (no) Preparation of lodixanol
DE502006006590D1 (de) Biozide zusammensetzungen
DE602006007982D1 (de) Modular-indikations-sicherungshalter
DK1855674T3 (da) Sammensætning til hæmning af cathepsin k
DK1965831T3 (da) Anvendelse af C1-inhibitor til forebyggelse af iskæmi-reperfusionsskade
FI20055133A0 (fi) Iskulaite